FERRI NICOLA

PERSONAL DATA
Date of birth: October 25, 1971
Place of birth: Mede Lomellina (PV), Italy
Nationality: Italian
Mailing address: Department of Pharmaceutical Sciences
University of Padua
Largo Egidio Meneghetti 2
35131 Padua, Italy

EDUCATION
1990 Student in Pharmaceutical Chemistry and Technology, University of Milan, Italy
1996 Doctor in Pharmaceutical Chemistry and Technology, "Magna cum Laude", University of Milan, Italy
1998 Ph.D. in “Experimental Pharmacology” at the University of Milan, Italy
2002 Ph.D. in "Toxicology of Environment and Nutrition" at the University of Milan, Italy
2006 Master in “Pharmacy and Oncological Pharmacology” at the University of Milan, Italy

RESEARCH EXPERIENCE
Since 2021 Ful Professor, Department of Medicine, University of Padua, Padua, Italy
2018-2021 Associate Professor, Department of Pharmaceutical Science, University of Padua, Padua, Italy
2015-2018 Research Assistant Professor (RTD B), Department of Pharmaceutical Science, University of Padua, Padua, Italy
2014 – 2015 Research Assistant Professor (RTD A), Department of Biomolecular and Pharmacological Sciences, University of Milan, Italy
2003-2014 Post-Doctoral position at the University of Milan, Department of Pharmacological and Biomolecular Sciences, University of Milan, Italy
2004 "Visiting Scientist" (2 months) at the University of Washington (Seattle, USA) in the laboratory directed by Elaine Raines
1999-2003 "Senior Research Fellow" at the Department of Pathology, School of Medicine, University of Washington, Seattle, WA, USA in the Laboratory directed by Dr. Russell Ross and Prof. Elaine W. Raines
1999-2002 Doctoral Research in the laboratory directed by Prof. Remo Fumagalli, Institute of Pharmacological Sciences, University of Milan
1997-1999 Doctoral Research in the laboratory directed by Prof. Remo Fumagalli, Institute of Pharmacological Sciences, University of Milan

HONORS, SCOLARSHIPS, FELLOWSHIPS
1996-1998 Winner of a fellowship disposed by Pharmaceutical Company Tecnofarmaci S.C.p.A. Rome Italy.
1998-2002 Winner of a fellowship from Ph.D. school of Toxicology of Environment and Alimentation at the University of Milan
2003 Winner of scientific award "Giovanni Galli" at University of Milan, supported by Italian Society for the study of atherosclerosis (SISA).
2006 "Young Investigator Poster Award, Honorable Mention" at the XIV International Symposium of Atherosclerosis, Roma (Italia).
2006 Winner of the ward “Giovani Ricercatori” at University of Milan, supported by Italian Society for the study of atherosclerosis (SISA).
2007 Winner of Travel Grant SISA for the XXI National Congress of Italian Society for the study of atherosclerosis (SISA), Perugia (ITALY).
2008 Winner of the award “Giovani Ricercatori” supported by Italian Society for the study of atherosclerosis (SISA), Milan, ITALY.
2013 Winner of Travel Grant SISA for the XXVII National Congress of Italian Society for the study of atherosclerosis (SISA), Rome (ITALY).

CONTRIBUTION TO EXPERIMENTAL RESEARCH
Principal Investigator

2000-2001 Principal Investigator of a grant supported by LAM foundation Cincinnati OH, USA titled ”Potential Role of New Collagen Receptors (DDR1 and DDR2) in Smooth Muscle Growth in LAM”
2016- Coordinator of research project “Investigating the relationship between PCSK9 and chronic inflammation associated with obesity and insulin resistance” (PRID, University of Padova, Department of Pharmaceutical and Pharmacological Sciences) (38.000 €)
2016- Coordinator of research project “Studio dell’efficacia di una nuova formulazione, TRIO, a base di vitamina K2 (MK-7), carbonato di magnesio e pirofosfato ferrico (ferro sucrosomiale, Pharmanutra spa) per la prevenzione delle calcificazioni arteriose in un modello animale di insufficienza renale” (Pharmanutra) (38.000 €)
2017- Grant from ANVUR n. 20/2017 del 15-06-2017 (3.000€)
2018- Coordinator of research project unit “Exploring the pathophysological role of PCSK9 in Alzheimer’s disease: focus on inflammation and lipid metabolism (exit-ad)” AMGEN competitive grant program, (250.000€)
2019- Coordinator of research project unit PRIN 2017 "Low density lipoprotein receptor (LDLR)-independent effects of proprotein convertase subtilisin/kexin type 9 (PCSK9): role in modulating insulin-resistance, ectopic fat accumulation and low-grade inflammation" (110.000€)
2020- Local coordinator of the project HORIZON 2020 RESEARCH AND INNOVATION ACTIONS (RIA)- Atrial fibrillation integrated approach in frail, multimorbid and polymedicated older people: AFFIRMO project. (Local Budget 143.000 €; total budget 6.000.000 €)

Collaborator
2005- Collaborator of the research program FP6-2004- LIFESCIHEALTH-5 "Drug design for Cardiovascular Disease: Integration of in Silico and in Vitro Analysis" CARDIOWORKBENCH.
2009- Collaborator of the research program “Farmacogenetica delle miopatie indotte da statine: implicazioni cliniche” (Call for the independent research Decreto 6716 Regione Lombardia)
2009- Collaborator of research program “Progettazione e sintesi di nuovi inibitori della proteina Rac1 e loro valutazione farmacologica nell'ambito della terapia cardiovascolare” (FIRB Young investigators; Italian Research Ministry)
2010- Collaborator of research program ““hit-to-lead” di inibitori delle proteine Rac: da molecola bioattiva a candidato farmaco” (Fondo per la promozione di Accordi Istituzionali, Finlombarda S.p.A)
2011- Collaborator of research program “Synthesis and pharmacological characterization of antiproliferative and NO-donor hybrids: a new strategy in the control of atherosclerosis” (Italian Research Ministry)
2013- Collaborator of research program “Investigating the role of pro-protein convertase subtilisin/kexin type 9 (PCSK9) released from smooth muscle cells on atherogenesis” (Cariplo Foundation)
2015- Collaborator of research program “Predicting statin-associated muscle symptoms for a personalized hypocholesterolemic therapy” (Ministry of Foreign Affairs and International Cooperation)

OTHER ACTIVITIES
From 2005- Member of the internal committee of Master in “Oncology Pharmacy” University of Milan
2004- XV International Symposium on "Drugs affecting lipid metabolism", Venice (Local Organizing Committee).
SCIENTIFIC SOCIETIES
- Italian Society of Atherosclerosis (since 2004)
- Italian Society of Pharmacology (since 2013)
- European atherosclerosis Society (since 2004)

Member of the Academic Editorial Board of “Plos One”
Member of Editorial Board of “Journal of Cardiovascular Pharmacology”
Associate editor of Atherosclerosis Plus
Reviewer for: Arteriosclerosis, Thrombosis and Vascular Biology; Atherosclerosis; Journal of Cardiovascular Pharmacology; American Journal of Pathology; Biochemical Pharmacology, British Journal of Pharmacology; Circulation Research, Thrombosis Research
Reviewer of research project submitted to “Fondation Recherche Medicale” (France)
Reviewer of research project submitted to “Israel Science Foundation (Israel)

Padua, 16th May 2023
Nicola Ferri